Not applicableStudy completedNCT00596102What this trial is testingLongterm Immunogenicity of the Japanese Encephalitis Vaccine IC51Who this might be right forJapanese Encephalitis Valneva Austria GmbH 3,258
Large-scale testing (Phase 3)Study completedNCT00840801What this trial is testingImmunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in ChildrenWho this might be right forEncephalitis, Tick-Borne Pfizer 302
Not applicableStudy completedNCT00001994What this trial is testingA Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineWho this might be right forToxoplasmosis, CerebralHIV Infections Glaxo Wellcome
Post-approval studies (Phase 4)Study completedNCT00311441What this trial is testingStudy of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy ChildrenWho this might be right forEncephalitis, Tick-Borne Novartis 300
Post-approval studies (Phase 4)Study completedNCT01562444What this trial is testingStudy to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination SchedulesWho this might be right forTick Borne EncephalitisVirus Diseases GlaxoSmithKline 206
Not applicableStudy completedNCT00002064What this trial is testingToxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of RelapseWho this might be right forToxoplasmosis, CerebralHIV Infections Palo Alto Medical Foundation
Not applicableLooking for participantsNCT01730131What this trial is testingNatural History Study of Progressive Multifocal Leukoencephalopathy (PML)Who this might be right forProgressive Multifocal Leukoencephalopathy National Institute of Neurological Disorders and Stroke (NINDS) 700
Post-approval studies (Phase 4)Study completedNCT02532569What this trial is testingLong-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis VaccineinjWho this might be right forJapanese Encephalitis Boryung Pharmaceutical Co., Ltd 94
Post-approval studies (Phase 4)Study completedNCT01815073What this trial is testingImmunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineWho this might be right forJapanese EncephalitisChickenpox Changchun Keygen Biological Products Co., Ltd. 497
Early research (Phase 1)Study completedNCT01984983What this trial is testingStudy of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy VolunteersWho this might be right forVenezuelan Equine Encephalitis Virus Infection Ichor Medical Systems Incorporated 42
Testing effectiveness (Phase 2)Study completedNCT00002395What this trial is testingSafety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)Who this might be right forHIV InfectionsLeukoencephalopathy, Progressive Multifocal SmithKline Beecham 54
Testing effectiveness (Phase 2)Study completedNCT00000794What this trial is testingPhase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic EncephalitisWho this might be right forToxoplasmosis, CerebralHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Ended earlyNCT00927953What this trial is testingTreatment of West Nile Virus With MGAWN1Who this might be right forWest Nile Neuroinvasive DiseaseWest Nile Virus InfectionEncephalitis+3 more MacroGenics 13
Large-scale testing (Phase 3)Study completedNCT04648241What this trial is testingStudy to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and OlderWho this might be right forTick-Borne Encephalitis Pfizer 165
Large-scale testing (Phase 3)Study completedNCT01296360What this trial is testingOpen-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic CountryWho this might be right forJapanese Encephalitis Valneva Austria GmbH 300
Not applicableEnrolling By InvitationNCT07186881What this trial is testingEvolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and MeningoencephalitisWho this might be right forTick BitesEncephalitisMeningitis+1 more Central Hospital, Nancy, France 200
Large-scale testing (Phase 3)Study completedNCT00161863What this trial is testingSafety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 YearsWho this might be right forTick-borne Encephalitis Pfizer
Not applicableLooking for participantsNCT03956446What this trial is testingTick-borne Encephalitis and Borrelial Antibodies in SerumWho this might be right forTick Borne Encephalitis University Medical Centre Ljubljana 80
Large-scale testing (Phase 3)Study completedNCT01246479What this trial is testingLong Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-StudyWho this might be right forJapanese Encephalitis Valneva Austria GmbH 23
Early research (Phase 1)Ended earlyNCT00091845What this trial is testingAn Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) DiseaseWho this might be right forWest Nile Fever Sarepta Therapeutics, Inc. 50